Clinical Trials for Kiora Pharmaceuticals

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Kiora Pharmaceuticals

Clinical Trials (3)

NCT06628947
A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa
PHASE2Recruiting
36 participants
Started: Aug 29, 2025 · Completed: Aug 31, 2027
1 condition1 sponsor5 locations
NCT06825702
Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema
PHASE2Recruiting
28 participants
Started: May 1, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor4 locations
NCT05282953
A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS)
PHASE1/PHASE2Recruiting
12 participants
Started: Nov 10, 2022 · Completed: Jul 31, 2026
2 conditions1 sponsor2 locations